Since it has been shown that the anti-inflammatory and antioxidant effects of BCP in the rotenone-induced PD rat model were mediated by the activation of CB2 receptors, it should be considered that CB2 receptors could be a promising therapeutic target for PD and that BCP might represent a potential interesting molecule for PD treatment [67]. The gene discussed is OPN1SW; the disease is Parkinson disease.